GSK

GSK Agrees to Settle About 80,000 Zantac Lawsuits for up to $2.2 Billion

Oct 14, 2024

GSK has agreed to pay up to $2.2 billion to settle the majority of lawsuits in U.S. state courts that allege a discontinued version of the heartburn drug Zantac caused cancer. The company announced this agreement on Wednesday, stating it resolves about 80,000 cases, or 93% of the pending lawsuits against it in state courts…
GSK Settles Two California Lawsuits Related to Heartburn Drug Zantac

Sep 19, 2024

British drugmaker GSK (GSK.L) announced on Wednesday that it has agreed to settle two lawsuits in California alleging that its discontinued heartburn drug Zantac caused cancer. GSK stated it does not admit to any liability in these settlements. Over the past 12 months, GSK has resolved a series of lawsuits related to Zantac, including several…
GSK Knew About Zantac Cancer Risk, Attorneys Tell Jury In First Trial

May 3, 2024

U.S. attorneys representing a woman who alleges her colon cancer stems from the now-discontinued heartburn drug Zantac told a Chicago jury on Thursday that pharmaceutical giants GSK and Boehringer Ingelheim were aware that improper handling of the product could lead to cancer but failed to issue warnings to the public. Mikal Watts, representing 89-year-old Angela…

About Us

Get the latest news straight to your inbox.